(2S,4S)-Sacubitril

CAS No. 149709-63-7

(2S,4S)-Sacubitril ( Sacubitril Impurity C )

Catalog No. M27052 CAS No. 149709-63-7

(2S,4S)-Sacubitril is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 448 Get Quote
10MG 683 Get Quote
25MG 1161 Get Quote
50MG 1764 Get Quote
100MG 2673 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    (2S,4S)-Sacubitril
  • Note
    Research use only, not for human use.
  • Brief Description
    (2S,4S)-Sacubitril is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.
  • Description
    (2S,4S)-Sacubitril is a stereoisomer derived from Sacubitril which is a potent NEP inhibitor.
  • Synonyms
    Sacubitril Impurity C
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    SARS-CoV-2 3CL
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    149709-63-7
  • Formula Weight
    430.5
  • Molecular Formula
    C24H28NO5 1/2Ca
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C([O-])CCC(N[C@@H](C[C@H](C)C(OCC)=O)CC1=CC=C(C2=CC=CC=C2)C=C1)=O.O=C([O-])CCC(N[C@@H](C[C@H](C)C(OCC)=O)CC3=CC=C(C4=CC=CC=C4)C=C3)=O.[Ca+2]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Yuto Unoh, et al. Discovery of S-217622, a Non-Covalent Oral SARS-CoV-2 3CL Protease Inhibitor Clinical Candidate for Treating COVID-19. bioRxiv 2022.01.26.477782.
molnova catalog
related products
  • Ethyl oleate

    Ethyl oleate is the liquid lipid component in nanostructured lipid carriers (NLCs).?NLC is a promising vehicle for oral trans-Ferulic acid (TFA) administration.?

  • NITIDINE

    Nitidine is a bioactive plant benzophenanthridine alkaloid isolated from the root of Zanthoxylum nitidum.

  • P-gp inhibitor 1

    P-gp inhibitor 1 inhibits reversing P-glycoprotein-mediated multidrug resistance with an EC50 of 57.9 nM (K562/A02 cells).